Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
EDAP	EDAP TMS SA	$152.93M	-155.00%	-44.50%	-75.17%	-76.10%	6.13	1.34	43.40%	-41.80%	-34.73%
INBS	INTELLIGENT BIO SOLUTIONS INC	$5.10M	-197.90%	-99.20%	-89.49%	-470.70%	0.61	2.38	56.30%	-256.40%	-254.49%
DYAI	DYADIC INTERNATIONAL INC	$26.35M	-695.80%	-78.20%	-110.39%	-122.90%	7.07	2.68	24.90%	-238.30%	-223.56%
RADX	RADIOPHARM THERANOSTICS LTD	$29.51M	-99.40%	-45.70%	-50.41%	-149.70%	0.97	2.67	1.10%	-997.40%	-992.74%
CTSO	CYTOSORBENTS CORP	$36.74M	-79.90%	-17.40%	-17.37%	-11.30%	6.49	2.13	71.50%	-22.10%	-16.15%
PPBT	PURPLE BIOTECH LTD	$7.16M	98.50%	83.40%	278.72%	-984.90%	0.82	1.27	N/A	N/A	N/A
DARE	DARE BIOSCIENCE INC	$38.29M	N/A	-56.50%	-152.46%	129.30%	10.42	1.14	71.30%	-1,300.70%	-1,300.66%
DRIO	DARIOHEALTH CORP	$63.37M	-88.00%	-54.70%	-38.30%	-119.20%	0.62	3.76	56.60%	-276.10%	-172.59%
IPHA	INNATE PHARMA SA	$127.46M	N/A	-56.60%	-176.67%	-145.70%	-3.89	1.28	100.00%	-546.10%	-511.46%
XRTX	XORTX THERAPEUTICS INC	$3.38M	-120.30%	-90.50%	-127.43%	-326.80%	0.29	2.11	N/A	N/A	N/A
NCNA	NUCANA PLC	$0.00	-190.00%	-130.50%	-71.37%	1,079.00%	0.23	5.60	N/A	N/A	N/A
INCR	INTERCURE LTD	$44.29M	-9.00%	-4.90%	-2.42%	-2.80%	0.74	0.96	12.30%	-13.20%	-4.27%
AKTX	AKARI THERAPEUTICS PLC	$7.00M	-70.30%	-35.50%	-48.82%	120.00%	0.69	0.44	N/A	N/A	N/A
IINN	INSPIRA TECHNOLOGIES OXY BHN LTD	$15.03M	-397.90%	-197.20%	-511.76%	-1,243.90%	1.30	1.56	0.70%	-4,574.40%	-4,457.09%
AEMD	AETHLON MEDICAL INC	$2.88M	-219.40%	-164.30%	-169.29%	-3,159.60%	0.20	5.68	N/A	N/A	N/A
APLM	APOLLOMICS INC	$32.17M	-1,305.40%	-110.40%	-2,801.80%	307.00%	-3.11	0.96	100.00%	-128.70%	-127.89%
XAIR	BEYOND AIR INC	$5.65M	-279.60%	-98.50%	-88.55%	-87.70%	3.51	5.12	1.80%	-447.70%	-406.50%
XBIT	XBIOTECH INC	$76.22M	-27.80%	-26.70%	-31.81%	-224.60%	0.07	16.01	N/A	N/A	N/A
VSEE	VSEE HEALTH INC	$8.18M	-541.50%	-69.40%	-191.83%	105.90%	3.11	0.52	50.30%	-100.60%	-80.94%
XTNT	XTANT MEDICAL HOLDINGS INC	$70.59M	10.30%	5.00%	16.50%	13.50%	0.85	2.65	62.90%	3.70%	7.97%
DRMA	DERMATA THERAPEUTICS INC	$4.99M	-130.90%	-102.20%	N/A	-2,531.20%	0.26	N/A	N/A	N/A	N/A
CNTA	CENTESSA PHARMACEUTICALS PLC	$6.13B	-60.40%	-44.20%	-39.34%	-40.00%	0.32	9.53	N/A	N/A	N/A
MOBI	MOBIA MEDICAL INC	N/A	N/A	N/A	-119.99%	N/A	-0.13	4.54	81.10%	-145.10%	-142.08%
FEMY	FEMASYS INC	$22.77M	-258.10%	-73.70%	-80.87%	-103.20%	1.26	3.91	61.60%	-521.80%	-453.89%
XOMA	XOMA ROYALTY CORP	$523.59M	23.70%	7.70%	13.81%	14.80%	1.71	3.59	100.00%	41.10%	67.91%
CMND	CLEARMIND MEDICINE INC	$809.91k	-207.50%	-100.70%	-80.17%	383.20%	0.35	3.79	N/A	N/A	N/A
CMMB	CHEMOMAB THERAPEUTICS LTD	$13.24M	-82.40%	-71.80%	-72.93%	-234.10%	0.12	9.08	N/A	N/A	N/A
CCRN	CROSS COUNTRY HEALTHCARE INC	$424.20M	-27.10%	-19.80%	-23.33%	-45.90%	0.44	3.29	20.20%	-9.80%	-8.39%
EVGN	EVOGENE LTD	$6.63M	N/A	-29.70%	-39.46%	-43.70%	-98.43	4.54	-6.30%	-220.20%	-170.02%
ESPR	ESPERION THERAPEUTICS INC	$805.76M	N/A	-1.80%	48.95%	14.60%	-2.50	1.53	68.40%	-1.80%	18.98%
XTLB	XTL BIOPHARMACEUTICALS LTD	$6.90M	-26.80%	-18.70%	-18.24%	911.00%	0.57	0.61	0.70%	-227.70%	-256.54%
AMS	AMERICAN SHARED HOSPITAL SERVICES	$11.42M	-6.40%	-2.60%	-1.47%	-0.80%	1.16	0.76	18.00%	-5.50%	-1.68%
ENSC	ENSYSCE BIOSCIENCES INC	$2.94M	-375.00%	-195.50%	-352.09%	20,346.20%	1.42	1.59	N/A	N/A	N/A
ICCM	ICECURE MEDICAL LTD	$17.55M	-221.00%	-118.90%	-166.53%	-1,114.80%	0.53	2.61	36.30%	-445.60%	-446.70%
COSM	COSMOS HEALTH INC	$15.60M	-81.70%	-30.10%	-60.73%	-44.70%	2.55	1.00	12.10%	-29.30%	-25.31%
APLS	APELLIS PHARMACEUTICALS INC	$5.26B	39.70%	13.20%	22.37%	22.90%	1.61	3.63	90.20%	12.10%	16.17%
CPHI	CHINA PHARMA HOLDINGS INC	$36.19M	-28.70%	-17.00%	-13.07%	-72.70%	0.36	0.32	-3.20%	-76.90%	-74.45%
ARAY	ACCURAY INC	$37.24M	-77.50%	-10.10%	-6.30%	-4.70%	9.73	1.42	26.80%	-10.80%	-3.56%
ELUT	ELUTIA INC	$44.92M	-225.80%	129.50%	142.45%	343.80%	1.25	2.22	53.70%	434.20%	431.19%
CLRB	CELLECTAR BIOSCIENCES INC	$12.38M	-282.30%	-146.90%	-213.04%	782.90%	0.59	2.96	N/A	N/A	N/A
VVOS	VIVOS THERAPEUTICS INC	$9.79M	-854.30%	-96.10%	-299.18%	-204.20%	-16.59	0.24	60.40%	-121.40%	-121.37%
INM	INMED PHARMACEUTICALS INC	$2.17M	-82.00%	-69.10%	-122.64%	-668.50%	0.33	3.12	35.90%	-262.20%	-261.62%
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	$28.59M	-63.90%	-48.80%	-65.42%	-329.50%	0.39	6.06	N/A	N/A	N/A
ZJYL	JIN MEDICAL INTERNATIONAL LTD	$19.18M	4.10%	2.40%	4.75%	4.00%	0.80	1.86	29.20%	5.80%	6.80%
YDES	YD BIO LTD	$367.40M	N/A	-67.70%	-68.50%	464.80%	-5.83	5.88	28.10%	-1,392.60%	-1,392.86%
VERU	VERU INC	$36.43M	-83.20%	-55.60%	-47.26%	-659.20%	0.28	5.16	N/A	N/A	N/A
LSTA	LISATA THERAPEUTICS INC	$29.69M	-101.90%	-83.10%	-155.79%	3,961.70%	0.31	4.23	100.00%	-9,618.20%	-9,845.88%
PMCB	PHARMACYTE BIOTECH INC	$8.48M	-22.60%	-18.00%	-6.06%	-9.70%	0.43	12.33	N/A	N/A	N/A
COCP	COCRYSTAL PHARMA INC	$18.06M	-132.60%	-89.80%	-117.72%	-315.10%	0.53	3.68	N/A	N/A	N/A
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	$5.19M	-114.10%	-77.20%	-141.61%	-193.60%	0.77	2.53	64.80%	-484.60%	-484.56%
XBIO	XENETIC BIOSCIENCES INC	$6.93M	-39.30%	-33.50%	-32.14%	647.90%	0.14	7.93	100.00%	-70.00%	-70.03%
AYTU	AYTU BIOPHARMA INC	$24.69M	-107.20%	-19.70%	-37.96%	-254.40%	7.59	1.16	66.80%	-39.00%	-34.20%
BMGL	BASEL MEDICAL GROUP LTD	$14.33M	-177.90%	-66.10%	-127.36%	-62.40%	2.44	1.31	77.50%	-94.00%	-95.84%
CELU	CELULARITY INC	$22.46M	N/A	-76.50%	-319.76%	-108.70%	-3.82	0.15	24.40%	-345.80%	-320.00%
PAVM	PAVMED INC	$41.49M	-10.10%	-8.70%	1.76%	1.10%	0.49	0.17	-207.00%	-5,315.50%	594.37%
QTI	QT IMAGING HOLDINGS INC	$91.40M	N/A	-146.30%	-121.73%	-223.00%	2.57	2.81	45.40%	-111.40%	-97.46%
DWTX	DOGWOOD THERAPEUTICS INC	$56.78M	-147.80%	-37.80%	-38.96%	6,048.10%	0.20	2.76	N/A	N/A	N/A
BMRA	BIOMERICA INC	$7.08M	-98.10%	-70.40%	-125.20%	-202.70%	0.47	2.64	4.30%	-96.50%	-96.00%
BNBX	BNB PLUS CORP	$2.58M	-726.30%	-586.80%	-171.96%	-771.50%	0.12	2.32	25.50%	-3,438.00%	-1,549.21%
BYSI	BEYONDSPRING INC	$57.16M	N/A	-3.30%	-7.41%	-9.60%	-1.55	1.54	N/A	N/A	N/A
ZTEK	ZENTEK LTD	$93.09M	-61.30%	-45.40%	-58.04%	-56.00%	0.41	1.00	57.10%	-857.10%	-865.02%
CABR	CARING BRANDS INC	$9.73M	N/A	N/A	N/A	N/A	-0.19	5.65	N/A	N/A	N/A
CALC	CALCIMEDICA INC	$9.95M	N/A	-139.10%	-553.70%	-171.10%	-8.80	1.61	N/A	N/A	N/A
ZYBT	ZHENGYE BIOTECHNOLOGY HOLDING LTD	$47.87M	-26.10%	-15.00%	-17.50%	-16.10%	0.52	1.14	20.50%	-60.00%	-47.51%
CLLS	CELLECTIS SA	$286.46M	-69.40%	-19.50%	-9.47%	-7.40%	3.28	1.62	100.00%	-84.90%	-21.30%
BGMS	BIO GREEN MED SOLUTION INC	$5.19M	-273.20%	-230.30%	-43.65%	-471.20%	0.20	4.70	18.50%	-1,886.50%	-400.40%
BOLT	BOLT BIOTHERAPEUTICS INC	$9.19M	-100.90%	-48.20%	-72.71%	-47.80%	1.42	3.51	100.00%	-455.10%	-455.15%
BNGO	BIONANO GENOMICS INC	$13.98M	-56.20%	-34.40%	-51.99%	-45.10%	0.66	1.98	46.30%	-92.60%	-92.35%
BLRX	BIOLINERX LTD	$16.24M	-6.00%	-2.80%	0.36%	3.50%	0.97	1.95	80.50%	-99.60%	8.90%
CYCN	CYCLERION THERAPEUTICS INC	$13.77M	-62.10%	-55.10%	-77.69%	-103.70%	0.25	1.80	100.00%	-264.70%	-264.73%
CUPR	CUPRINA HOLDINGS (CAYMAN) LTD	$5.32M	-1,569.10%	-91.20%	-86.45%	663.90%	0.68	2.35	-1.30%	-9,366.80%	-9,337.38%
CURX	CURANEX PHARMACEUTICALS INC	$9.28M	-64.50%	-61.20%	-36.85%	-98.60%	0.03	81.94	N/A	N/A	N/A
BFRI	BIOFRONTERA INC	$11.76M	-1,139.00%	-52.20%	-60.35%	-120.20%	1.73	1.52	73.70%	-25.30%	-24.12%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	605	+0.40%	+0.58%	+1.76%	-3.27%	16.80x	5.01x	-131.85%	-13.06%	-9.39%	+60.73%	Strong Buy
Diagnostics & Research	55	+0.42%	-4.98%	-7.03%	+5.12%	15.41x	3.31x	-6.51%	+6.26%	+12.44%	+28.72%	Strong Buy
Drug Manufacturers - General	20	+1.80%	+0.73%	+0.44%	+29.67%	34.44x	6.87x	+34.23%	+12.24%	+21.51%	+18.94%	Buy
Drug Manufacturers - Specialty & Generic	75	-0.07%	-5.65%	-0.82%	-32.38%	17.46x	1.56x	+6.49%	+4.90%	+10.71%	+42.42%	Buy
Healthcare Plans	10	+4.06%	+10.05%	+26.20%	-4.30%	27.11x	2.38x	+9.07%	+2.83%	+6.95%	-4.84%	Buy
Health Information Services	54	+0.27%	+1.05%	+7.97%	-78.02%	19.44x	2.93x	-2.99%	+0.89%	+2.30%	+44.87%	Buy
Medical Care Facilities	50	+1.66%	+5.55%	+2.89%	-24.05%	15.17x	5.01x	-47.65%	+6.75%	+20.11%	+18.57%	Buy
Medical Devices	139	+1.27%	-2.09%	-6.50%	-65.81%	21.70x	2.93x	+6.83%	+5.22%	+8.90%	+39.73%	Strong Buy
Medical Distribution	10	+0.82%	-9.31%	-15.06%	+4.97%	21.03x	137.01x	-103.91%	+3.58%	+25.34%	+34.54%	Buy
Medical Instruments & Supplies	55	+0.35%	-2.33%	-3.76%	-11.58%	44.01x	3.21x	+8.55%	+7.32%	+10.85%	+31.00%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1073 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 41, which is 14 points higher than the healthcare sector average of 27. It passed 13 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 50.45% over the past year, overperforming other healthcare stocks by 76 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 47.93% from Bioventus's current stock price of $10.14.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #2 top healthcare stock out of 1073 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 27, which is equal to the healthcare sector average of 27. It passed 9 out of 33 due diligence checks and has average fundamentals. Jazz Pharmaceuticals has seen its stock return 119.97% over the past year, overperforming other healthcare stocks by 146 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $237.67, an upside of 4.31% from Jazz Pharmaceuticals's current stock price of $227.84.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Jazz Pharmaceuticals, 58.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 8.33% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior Pharmaceuticals (NASDAQ:INDV)

Indivior Pharmaceuticals (NASDAQ:INDV) is the #3 top healthcare stock out of 1073 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior Pharmaceuticals (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Indivior Pharmaceuticals (NASDAQ:INDV) has a Due Diligence Score of 41, which is 14 points higher than the healthcare sector average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Indivior Pharmaceuticals has seen its stock return 237.57% over the past year, overperforming other healthcare stocks by 263 percentage points.

Indivior Pharmaceuticals has an average 1 year price target of $48.00, an upside of 25.39% from Indivior Pharmaceuticals's current stock price of $38.28.

Indivior Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Indivior Pharmaceuticals, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 73 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. So Young International (NASDAQ:SY)

So Young International (NASDAQ:SY) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.5%.

So Young International's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) has an annual dividend yield of 17.6%, which is 15 percentage points higher than the healthcare sector average of 2.5%.

Embecta's dividend payout ratio of 31.2% indicates that its high dividend yield is sustainable for the long-term.

3. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 17.01%, which is 15 percentage points higher than the healthcare sector average of 2.5%.

Dominari Holdings's dividend payout ratio of -42.4% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.86% in the last day, and down -0.54% over the last week. Pacs Group was the among the top gainers in the healthcare sector, gaining 28.56% yesterday.

PACS Group shares are trading higher after the company reported better-than-expected Q1 financial results. Also, the company announced a $250 million share buyback.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 42 points higher than the healthcare sector average of 15. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -72.52% in the past year. It has underperformed other stocks in the healthcare sector by -47 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 71 points higher than the healthcare sector average of 15. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 457.22% in the past year. It has overperformed other stocks in the healthcare sector by 483 percentage points.

3. Auna Sa (NYSE:AUNA)

Auna Sa (NYSE:AUNA) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Auna Sa has a valuation score of 71, which is 56 points higher than the healthcare sector average of 15. It passed 5 out of 7 valuation due diligence checks.

Auna Sa's stock has dropped -29.29% in the past year. It has underperformed other stocks in the healthcare sector by -3 percentage points.

Are healthcare stocks a good buy now?

60.89% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 40.33% over the next year.

5.11% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.09% of healthcare stocks are rated B (Buy), 48.5% are rated C (Hold), 26.56% are rated D (Sell), and 7.73% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.07x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Indivior Pharmaceuticals (NASDAQ:INDV)

1. So Young International (NASDAQ:SY)

2. Embecta (NASDAQ:EMBC)

3. Dominari Holdings (NASDAQ:DOMH)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Indivior Pharmaceuticals (NASDAQ:INDV)

1. So Young International (NASDAQ:SY)

2. Embecta (NASDAQ:EMBC)

3. Dominari Holdings (NASDAQ:DOMH)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.